If you liked this article you might like

Biotech Premarket Movers: Cempra, Tesaro, Editas
Allergan, Editas Sign Gene-Editing Pact for Rare Eye Diseases
Biotech Premarket Movers: Editas, Amphastar, Aratana, Pacira
Editas Medicine COO to Leave Company